ACM
INO icon

ADAR1 Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

ADAR1 Capital Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75,500
Closed -$131K – 325
2025
Q4 		$131K Buy
+75,500
New +$166K 0.01% 243

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ADAR1 Capital Management's INO Position: Q2 2026 in Review

ADAR1 Capital Management increased its Inovio Pharmaceuticals (INO) stake by 46% in Q2 2026, buying an estimated $800K and bringing the position to 2,143,910 shares worth $2.36M. The position accounts for 0.11% of the portfolio, ranked #137.

ADAR1 Capital Management first reported a position in INO in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.58M in Q4 2025. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • ADAR1 Capital Management held 2,143,910 shares of Inovio Pharmaceuticals worth $2.36M as of Q2 2026.
  • ADAR1 Capital Management bought 673,802 Inovio Pharmaceuticals shares in Q2 2026, an estimated $800K.
  • Inovio Pharmaceuticals made up 0.11% of ADAR1 Capital Management's portfolio in Q2 2026, its #137 holding.
  • ADAR1 Capital Management first reported a position in Inovio Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • ADAR1 Capital Management's Inovio Pharmaceuticals position peaked at $2.58M in Q4 2025.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.